Prentiss Christopher B
Chief Financial Officer at Adamas Pharmaceuticals Inc
- Sold, on record
- $96k
- Dollars the filings state
- Form 4 sales
- 9
- Latest Mar 22, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Adamas Pharmaceuticals IncChief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Adamas Pharmaceuticals IncPlan not statedDec 20, 2018 2018
Sold 228 shares at $7.51 ($2k)
Prentiss Christopher B, Chief Accounting Officer
Sold 1.2% of holdings ($139k position)18,226 shares leftFiling
- 2 Form 4 sale Adamas Pharmaceuticals IncPlan not statedMar 20, 2019 +90 days
Sold 1,185 shares at $8.00 ($9k)
Prentiss Christopher B, Chief Accounting Officer
Sold 3.9% of holdings ($246k position)29,541 shares leftFiling
- 3 Form 4 sale Adamas Pharmaceuticals IncPlan not statedJul 22, 2019 +124 days
Sold 1,082 shares at $6.00 ($6k)
Prentiss Christopher B, Chief Accounting Officer
Sold 2.2% of holdings ($290k position)47,209 shares left1.9x usual sizeFiling
- 4 Form 4 sale Adamas Pharmaceuticals IncPlan not statedJan 21, 2020 +183 days
Sold 1,269 shares at $5.92 ($8k)
Prentiss Christopher B, Chief Financial Officer
Sold 1.8% of holdings ($427k position)70,940 shares left1.5x usual sizeFiling
- 5 Form 4 sale Adamas Pharmaceuticals IncPlan not statedNov 2, 2020 +286 days
Sold 2,050 shares at $3.21 ($7k)
Prentiss Christopher B, Chief Financial Officer
Sold 2.5% of holdings ($260k position)78,890 shares left1.8x usual sizeFiling
- 6 Form 4 sale Adamas Pharmaceuticals IncPlan not statedJan 20, 2021 +79 days
Sold 2,630 shares at $4.41 ($12k)
Prentiss Christopher B, Chief Financial Officer
Sold 3.3% of holdings ($348k position)76,260 shares left2.1x usual sizeFiling
- 7 Form 4 sale Adamas Pharmaceuticals IncUnusualFeb 1, 2021 +12 days
Sold 3,821 shares at $6.36 ($24k)
Prentiss Christopher B, Chief Financial Officer
Sold 5% of holdings ($485k position)72,439 shares left3x usual sizeFiling
- 8 Form 4 sale Adamas Pharmaceuticals IncPlan not statedMar 22, 2021 +49 days
Sold 2,422 shares at $5.48 ($13k)
Prentiss Christopher B, Chief Financial Officer
Sold 1.6% of holdings ($808k position)145,017 shares left1.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 22, 2021 | Mar 23, 2021 | Adamas Pharmaceuticals Inc | Chief Financial Officer | Form 4 sale | 2,422 | $13k | 1.6% | Plan not stated | SEC |
| Feb 1, 2021 | Feb 1, 2021 | Adamas Pharmaceuticals Inc | Chief Financial Officer | Form 4 sale | 3,821 | $24k | 5.0% | Unusual | SEC |
| Jan 20, 2021 | Jan 22, 2021 | Adamas Pharmaceuticals Inc | Chief Financial Officer | Form 4 sale | 2,630 | $12k | 3.3% | Plan not stated | SEC |
| Nov 2, 2020 | Nov 2, 2020 | Adamas Pharmaceuticals Inc | Chief Financial Officer | Form 4 sale | 2,050 | $7k | 2.5% | Plan not stated | SEC |
| Jan 21, 2020 | Jan 23, 2020 | Adamas Pharmaceuticals Inc | Chief Financial Officer | Form 4 sale | 1,269 | $8k | 1.8% | Plan not stated | SEC |
| Jul 22, 2019 | Jul 23, 2019 | Adamas Pharmaceuticals Inc | Chief Accounting Officer | Form 4 sale | 1,082 | $6k | 2.2% | Plan not stated | SEC |
| Mar 20, 2019 | Mar 21, 2019 | Adamas Pharmaceuticals Inc | Chief Accounting Officer | Form 4 sale | 1,185 | $9k | 3.9% | Plan not stated | SEC |
| Dec 20, 2018 | Dec 26, 2018 | Adamas Pharmaceuticals Inc | Chief Accounting Officer | Form 4 sale | 228 | $2k | 1.2% | Plan not stated | SEC |
| Mar 21, 2018 | Mar 22, 2018 | Adamas Pharmaceuticals Inc | Chief Accounting Officer | Form 4 sale | 567 | $15k | 3.1% | Plan not stated | SEC |